Literature DB >> 1690745

Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells.

C A Conover1, P D Lee.   

Abstract

A human hepatoma cell line, HepG2, secretes a discrete insulin-like growth factor-binding protein (IGFBP-1) into serum-free medium, which is identical to the 25K mol wt BP in amniotic fluid and plasma. IGFBP-1 levels in vivo have been shown to be inversely correlated with circulating insulin concentrations. This study investigated the direct effects of insulin on IGFBP-1 production in vitro. Addition of insulin to HepG2 cultures induced a rapid dose-dependent decrease in IGFBP-1 synthesis and secretion independent of the glucose concentration in the medium. As assessed by ligand binding and specific RIA, levels of IGFBP-1 were 20-50% of control levels in 18-h conditioned medium from insulin-treated cells. Monoclonal antibody studies indicated that the suppressive effect of insulin on IGFBP-1 synthesis was mediated through specific interaction with the insulin receptor. Therefore, HepG2 cells respond to insulin by altering the synthesis and secretion of IGFBP-1 in a manner that mimics many of the changes in plasma IGFBP-1 levels observed in vivo and provide an in vitro model for studies of IGFBP-1 biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690745     DOI: 10.1210/jcem-70-4-1062

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Regulation of gene expression by insulin.

Authors:  R M O'Brien; D K Granner
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

2.  Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.

Authors:  C Invitti; L Fatti; M G Camboni; L Porcu; L Danesi; G Delitala; F Cavagnini
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

3.  A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.

Authors:  C A Conover
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 4.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

5.  In vitro assessment of hepatoprotective agents against damage induced by acetaminophen and CCl4.

Authors:  Liliana Torres González; Noemí Waksman Minsky; Linda Elsa Muñoz Espinosa; Ricardo Salazar Aranda; Jonathan Pérez Meseguer; Paula Cordero Pérez
Journal:  BMC Complement Altern Med       Date:  2017-01-13       Impact factor: 3.659

6.  A Box-Behnken Extraction Design and Hepatoprotective Effect of Isolated Eupalitin-3-O-β-D-Galactopyranoside from Boerhavia diffusa Linn.

Authors:  Kamal Y Thajudeen; Yahya I Asiri; Shahana Salam; Shabeer Ali Thorakkattil; Mohamed Rahamathulla; Ilyas Uoorakkottil
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

7.  Differential regulation of insulin-like growth factor binding protein-1 and -2 by insulin in the baboon (Papio anubis) endometrium.

Authors:  Steven D Fleming; Asgerally T Fazleabas; Stephen C Bell
Journal:  Reprod Biol Endocrinol       Date:  2008-01-31       Impact factor: 5.211

8.  Intracellular targeting of the insulin-regulatable glucose transporter (GLUT4) is isoform specific and independent of cell type.

Authors:  P M Haney; J W Slot; R C Piper; D E James; M Mueckler
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.